Brief: Impedimed Enters Agreement For Its Sozo Platform In Patients With End Stage Renal Disease
11/02/2022 01:12
Feb 11 (Reuters) - ImpediMed Ltd IPD.AX :
* ENTERED CLINICAL TRIAL AGREEMENT FOR ITS SOZO PLATFORM IN
PATIENTS WITH END STAGE RENAL DISEASE
Source text for Eikon: ID:nASX5npQtT
Further company coverage: IPD.AX
((Reuters.Briefs@thomsonreuters.com;))